Docket #: S18-199
Health Assessment Questionnaire (HAQ)
About the HAQ
The Health Assessment Questionnaire (HAQ) was developed by Professor James Fries and colleagues at Stanford University, first published in 1980. It was among the first patient-reported outcome instruments built around patient-centered dimensions of health. The most widely used component, the HAQ Disability Index (HAQ-DI), assesses functional ability across 20 questions in 8 categories, has been translated into more than 60 languages, and is a standard outcome measure in rheumatoid arthritis clinical trials and beyond.
Download
The HAQ is available under a CC BY-NC-SA 4.0 license. See the full license terms for details on attribution, sharing, and commercial use.
FAQ
Can I use the HAQ in my research?
Yes, for non-commercial purposes under the CC BY-NC-SA 4.0 license.
Can I translate or adapt it?
Yes, under the same license terms.
Can I use it commercially?
No. The license does not permit commercial use.
Is support available from Stanford?
No. Dr. Fries passed away in December 2021 and no additional support, consultation, or scoring guidance is available. Please consult the published literature.
Applications
- Outcome measurement in rheumatoid arthritis (RA) clinical trials and treatment strategy evaluation
- Patient-reported functional assessment across rheumatic and other chronic diseases
- Prediction of successful aging and examination of mortality risks
- Quantification of drug-related adverse effects (e.g., NSAID gastropathy) and development of disease risk factor models
Advantages
- Established as a valuable, effective, and sensitive tool across diverse clinical areas
- Translated into 60+ languages with extensive international validation
- Brief, standardized 20-question format applicable to both disease-specific and general health contexts
Publications
- Bruce, B., & Fries, J. F. (2003). The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation. Journal of Rheumatology, 30(1), 167–178.
Related Links
Similar Technologies
-
Metabolic Subphenotype Predictor – software for continuous glucose monitoring S21-137Metabolic Subphenotype Predictor – software for continuous glucose monitoring
-
G-I-ntelligent pill (GIntellipill) for active sample collection in the gastrointestinal tract S24-095G-I-ntelligent pill (GIntellipill) for active sample collection in the gastrointestinal tract
-
DART-Met: Dynamic AI-Driven Raman Techniques for Biomarker monitoring in Metabolic disorders S25-113DART-Met: Dynamic AI-Driven Raman Techniques for Biomarker monitoring in Metabolic disorders